Casazza JP, Cale EM, Narpala S, Yamshchikov GV, et al. Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial. Nat Med 2022 Apr 11. pii: 10.1038/s41591-022-01762.
PMID: 35411076